Use of intravenous ketorolac in the neonate and premature babies

Paediatric Anaesthesia

Volumn 14, Issue 6, 2004, Pages 487-492

  Papacci, Patrizia ^a,c   De Francisci, Giovanni ^b   Iacobucci, Tiziana ^b   Giannantonio, Carmen ^a   De Carolis, Maria Pia ^a   Zecca, Enrico ^a   Romagnoli, Costantino ^a  

^a UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

^b Inst Anaesthiol Intensive Care L   (Italy)

^c NONE   (Italy)

Author keywords

Analgesia; Chronic lung disease; Ketorolac; Pain; Preterm neonate

Indexed keywords

ANALGESIC AGENT; KETOROLAC; NONSTEROID ANTIINFLAMMATORY AGENT;

ANALGESIC ACTIVITY; ARTICLE; BLOOD ANALYSIS; BREATHING PATTERN; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; DRUG CHOICE; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS ANESTHESIA; MALE; NEWBORN; NEWBORN SURGERY; PAIN ASSESSMENT; PEDIATRIC ANESTHESIA; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; PREMATURITY; PRIORITY JOURNAL;

EID: 2942545806     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2004.01250.x     Document Type: Article

References (38)

1. American Academy of Pediatrics and Canadian Pediatrics Society. Prevention and Management of pain and stress in the neonate. Pediatrics 2000; 105: 454-161.
2. Yaster M, Deshpande JK. Management of pediatric pain with opioid analgesics. J Pediatr 1988; 113: 421-429.
3. Gillis JC, Brogden RN. Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs 1997; 53: 139-188.
4. Yeh TF, Achanti B, Patel H et al. Indomethacin therapy in premature infants with patent ductus arteriosus: determination of therapeutic plasma levels. Dev Pharmacol Ther 1989; 12: 169-178.
5. Patel J, Marks KA, Roberts I et al. Ibuprofen treatment of patent ductus arteriosus. Lancet 1995; 346: 255.
6. Van Overmeire B, Follens I, Hartmann S et al. Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child 1997; 76: F179-F184.
7. Varvarigou A, Bardin CL, Beharry K et al. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 1996; 275: 539-544.
8. De Carolis MP, Romagnoli C, Papacci P et al. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. Eur J Pediatr 2000; 159: 364-368.
9. Stevens B, Koren G. Evidence-based pain management for infants. Curr Opin Pediatr 1998; 10: 203-207.
10. Olkkola KT, Maunuksela EL. The pharmacokinetics of post-operative intravenous ketorolac tromethamine in children. Br J Clin Pharmacol 1991; 31: 182-184.
11. Lawrence J, Alcock D, McGrath P et al. The development of a tool to assess neonatal pain. Neonat Netw 1993; 12: 59-66.
12. Van Lingen RA, Greijdanus B, Okken A et al. Morphine concentration assessed by EPIA in relation to pain assessed by NIPS in preterm infants. In: In the Abstract Book of Fourth International Symposium on Pediatric Pain. Helsinki: 1997, abstract no. 53.
13. Heymann MA, Rudolph AM, Silverman NA. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 1976; 295: 530-533.
14. Rømsing J, Walther-Larsen S. Peri-operative use of non-steroidal anti-inflammatory drugs in children: analgesic efficacy and bleeding. Anaesthesia 1997; 52: 673-683.
15. Larsson BA. Pain management in neonates. Acta Paediatr 1999; 88: 1301-1310.
16. Howard CR, Howard FM, Weitzman ML. Acetaminophen analgesia in neonatal circumcision: the effect of pain. Pediatrics 1994; 93: 641-646.
17. Friedman WF, Hirschlau MJ, Printz MP et al. Pharmacologic closure of the patent ductus arteriosus in the premature infant. N Engl J Med 1976; 295: 526-529.
18. Maunuksela EL, Kokki H, Bullingham RES. Comparison of intravenous ketorolac with morphine for postoperative pain in children. Clin Pharmacol Ther 1992; 52: 436-443.
19. Sutters KA, Levine JD, Dibble SC et al. Analgesic efficacy and safety of single-dose intramuscular ketorolac for postoperative pain management in children following tonsillectomy. Pain 1995; 61: 145-153.
20. Houck CS, Wilder RT, McDermott JS et al. Safety of intravenous ketorolac therapy in children and cost saving with a unit dosing system. J Pediatr 1996; 129: 292-296.
21. Chiaretti A, Simeone E, Langer A et al. Analgesic efficacy of ketorolac and fentanyl in pediatric intensive care. Pediatr Med Chir 1997; 19: 419-424.
22. Watcha MF, Jones MB, Lagueruela RG et al. Comparison of ketorolac and morphine as adjuvants during pediatric surgery. Anesthesiology 1992; 76: 368-372.
23. Gupta A, Cheng J, Wang S et al. Analgesic efficacy of ketorolac and morphine in neonatal rats. Pharmacol Biochem Behav 2001; 68: 635-640.
24. Anand KJS. Clinical importance of pain and stress in preterm neonates. Biol Neonate 1998; 73: 1-9.
25. Anand KJS, Coskun V, Thrivikraman KV et al. Long term behavioural effects of repetitive pain in neonatal rat pups. Physiol Behav 1999; 66: 627-637.
26. Anand KJS, Sippel WG, Aynsley-Green A. Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response. Lancet 1987; 1: 62-66.
27. Anand KJS, Aynsley-Green A. Measuring the severity of surgical stress in newborn infants. J Pediatr Surg 1988; 23: 297-305.
28. Anand KJS, Hickey PR. Halothane-morphine compared with high-dose sufentanil for anesthesia and postoperative analgesia in neonatal cardiac surgery. New Engl J Med 1992; 326: 1-9.
29. Truog R, Anand KJS. Management of pain in the postoperative neonate. Clin Perinatol 1989; 16: 61-78.
30. Booker PD. Postoperative analgesia for neonates? Anaesthesia 1987; 42: 343-345.
31. Krechel SW, Eggers GWN, Helikson MA. Intrathecal morphine for postoperative analgesia in an infant with bronchopulmonary dysplasia following upper abdominal surgery. Pediatr Anaesth 1996; 6: 423-426.
32. Hamunen K, Maunuksela EL. Ketorolac does not depress ventilation in children. Paed Anaesth 1996; 6: 79.
33. Brandon Bravo LJC, Mattie H, Spierdijk J et al. The effects on ventilation of ketorolac in comparison with morphine. Eur J Clin Pharmacol 1988; 35: 491-494.
34. Conrad KA, Fagan TC, Mackie MJ et al. Effects of ketorolac tromethamine on hemostasis on volunteers. Clin Pharm Ther 1988; 43: 542-546.
35. Greer IA. Effects of ketorolac tromethamine on hemostasis. Pharmacotherapy 1990; 10: S71-S76.
36. Greer IA, Johnston J, Tulloch I et al. Effect of maternal ketorolac administration on platelet function in the newborn. Eur J Obstet Gynecol Reprod Biol 1988; 29: 257-260.
37. Romagnoli C, Zecca E, Papacci P et al. Furosemide does not prevent indomethacin-induced renal side effects in preterm infants. Clin Pharmacol Ther 1997; 62: 181-186.
38. Meyers RL, Alpan G, Lin E et al. Patent ductus arteriosus, indomethacin, and intestinal distention: effects on intestinal blood flow and oxygen consumption. Pediatr Res 1991; 29: 569-574.